Nature Chemical Biology is a monthly, peer-reviewed, scientific journal, which is published by Nature Publishing Group. It was first published in June 2005 (volume 1, issue 1). Terry L. Sheppard is a full-time professional editor with the title, "Chief Editor", and employed by Nature Chemical Biology. The impact factor for Nature Chemical Biology in 2010 is 15.808, according to the Journal Citation Reports. The publishing focus of Nature Chemical Biology is a forum for original research and commentary in Chemical-biology. Published topics encompass concepts and research methods in chemistry, biology, and related disciplines with the end result of controlling biological systems at the molecular level. Authors (contributors) are chemical biologists, also chemists involved in interdisciplinary research between chemistry and biology, along with biologists who produce research results in understanding and controlling biological processes at the molecular level. Interdisciplinary research in chemistry and biology is emphasized. The journal s main focus in this area is fundamental research which illuminates available chemical and biological tools, as well as mechanisms underpinning
Researchers discover how opium poppies synthesize morphine
Many people who live in developing countries do not have access to the pain relief that comes from morphine or other analgesics. That's because opiates are primarily derived from the opium poppy plant (Papaver somniferum) ...
Expanding the DNA alphabet: 'Extra' DNA base found to be stable in mammals
Researchers from the University of Cambridge and the Babraham Institute have found that a naturally occurring modified DNA base appears to be stably incorporated in the DNA of many mammalian tissues, possibly representing ...
New 'TripAdvisor' site to address use of substandard biomedical research tools
An international panel of leading scientists is launching a new TripAdvisor-style website aimed at helping researchers choose better-quality research tools - and avoiding potentially serious errors in biomedical research.
Discovery lays the foundation for yeast-based drug synthesis
Fans of homebrewed beer and backyard distilleries already know how to employ yeast to convert sugar into alcohol. But a research team led by bioengineers at the University of California, Berkeley, has gone much further by ...
Body's response to spicy foods guides design of new pain relief drugs
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to ...
New type of drug can target all disease-causing proteins
Current drugs block the actions of only about a quarter of known disease-causing proteins, but Yale University researchers have developed a technology capable of not just inhibiting, but destroying every protein it targets.
New anti-microbial compounds evade resistance with less toxicity
New compounds that specifically attack fungal infections without attacking human cells could transform treatment for such infections and point the way to targeted medicines that evade antibiotic resistance.
Researchers discover new enzyme, link to iron in vitamin A synthesis
A research team's discovery of new information about how plants synthesize carotenoids, precursors for vitamin A that are essential for plant development and survival, and human health, could help scientists increase the ...
Simple method for selective bioconjugation of native proteins
Sugar structure: Not as sweet as it seems
Scientists at the University of York have identified problems with nearly half of the structural data on carbohydrate molecules available to the scientific community.